Cipla stock tanks 8% after USFDA warning over issues at MP unit
Warning letter stresses data integrity issues at company embedded with product complaints and microbial contamination
Warning letter stresses data integrity issues at company embedded with product complaints and microbial contamination
The FDA asks the company to "correct any violations promptly", failing which the global agency may withhold approval of new applications or supplements listing